BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2010
View Archived Issues
Omeros receives USD 25 million in funding for GPCR program
Read More
Data from several studies on mitoxantrone for relapsing-remitting MS made available
Read More
Merck & Co. identifies new renin inhibitors
Read More
Clinical trials explore efficacy of budesonide in treating eosinophilic esophagitis
Read More
Effects of denosumab reported in patients with prostate cancer and bone metastases
Read More
AstraZeneca and Daiichi Sankyo announce agreement to copromote Nexium in Japan
Read More
Results reported from second phase III study of aclidinium bromide in COPD
Read More
FDA requests additional information from VIVUS regarding Qnexa NDA
Read More
Cellceutix completes final toxicity study of Kevetrin
Read More
Emergent BioSolutions acquires Trubion Pharmaceuticals
Read More
Neuron BioPharma describes new antioxidants/HMG-CoA reductase inhibitors
Read More
Third quarter highlights at Abbott
Read More
Teva Pharma to acquire Theramex, a women's health business, from Merck Serono
Read More
Acadia enters agreement with Biovail to regain rights to pimavanserin
Read More
Shire reports data from phase II Vyvanse study in major depressive disorder
Read More
Mild toxicity and disease stabilizations seen with L19TNF-alpha in patients with cancer
Read More
Merck Serono presents new lysophospholipid S1P1 receptor agonists
Read More
New inhibitors of Ras-related C3 botulinum toxin substrate 1 claimed
Read More
GSK and Amicus to develop Amigal for Fabry's disease
Read More
StemCells begins second clinical trial of HuCNS-SC in Batten disease
Read More
FDA approves Avanir's Nuedexta for treatment of pseudobulbar affect
Read More
Inhibitex begins phase Ib trial of INX-189 in chronic HCV infections
Read More
Spectrum Pharma submits additional data to FDA for Fusilev
Read More
FDA approves Afinitor as first treatment for benign brain tumor associated with tuberous sclerosis
Read More